diversity
News/ News/ News/ Patients/ R&D
Pharmacy chain Walgreens plans to disrupt clinical trial sector
Phil Taylor
clinical trials, CVS, decentralised clinical trials, diversity, patients, Walgreens
0 Comment
Oncology/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis/ White Papers/ Whitepapers
The value of diverse patient representation and engagement in cancer treatment
mike.hammerton@pharmaphorum.com
cancer patients, cancer treatment, COVID-19, diversity, Envision Pharma Group, patient centricity
0 Comment
R&D/ Views & Analysis/ Views and analysis
Can technology help diversify clinical trials?
mike.hammerton@pharmaphorum.com
clinical trials, decentralised clinical trials, diversity, diversity and inclusion, KPMG
0 Comment
R&D/ Views & Analysis/ Views and analysis
Why are clinical trials struggling with diversity?
mike.hammerton@pharmaphorum.com
clinical trial diversity, clinical trials, COVID-19, diversity, diversity and inclusion, randomised control trials
0 Comment
Sales and Marketing/ Views & Analysis/ Views and analysis
When diversity, equity and inclusion are more than just buzzwords
mike.hammerton@pharmaphorum.com
diversity, diversity and inclusion, equity, Horizon Therapeutics, inclusion, Petra Molan
0 Comment
Digital/ News/ News/ News/ News/ Patients/ R&D
Financing pushes value of clinical trial tech firm Reify to $4.8bn
Phil Taylor
clinical trials, decentralised clinical trials, digital health, diversity, patients, recruitment, Reify Health
0 Comment
CVS, Medable alliance aims to tackle diversity in clinical trials
Phil Taylor
clinical trials, CVS Health, decentralised trials, digital, digital health, diversity, Medable, patient recruitment
0 Comment
Patients/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis
Importance of diversity in pharma and clinical trials
mike.hammerton@pharmaphorum.com
clinical trials, decentralised clinical trials, diversity, impetus, Natalie Yeadon, virtual clinical trials
0 Comment